Balanced designs for multiple crossover studies
- PMID: 1610429
Balanced designs for multiple crossover studies
Abstract
Experimental situations are considered, in which t different treatments are administered to n cases (volunteers, patients, animals etc.) during p periods (p less than or equal to t) in a way that each of these cases receives p different treatments in sequence (crossover designs). In order to minimize the influence of carry-over effects the designs of the trials are constructed with regard to three conditions of balance: (a) Each case receives the same number of treatments, (b) each treatment is applied the same number of times in each period, and (c) each possible transition between two consecutive periods appears the same number of times during the experiment. The minimal numbers of cases are given for complete (p = t) and incomplete (p less than t) designs balanced according to all the above mentioned conditions. Furthermore, the designs themselves (plans of the experiments) are also listed for the minimal number of cases for 2 less than or equal to p less than or equal to t less than or equal to 10.
Similar articles
-
Three-period crossover designs for two treatments.Biometrics. 1984 Mar;40(1):219-24. Biometrics. 1984. PMID: 6733230
-
CrossOver: an algorithm for the construction of efficient cross-over designs.Stat Med. 2004 Sep 15;23(17):2645-58. doi: 10.1002/sim.1860. Stat Med. 2004. PMID: 15316948
-
Crossover and self-controlled designs in clinical research.N Engl J Med. 1984 Jan 5;310(1):24-31. doi: 10.1056/NEJM198401053100106. N Engl J Med. 1984. PMID: 6689736
-
On design considerations and randomization-based inference for community intervention trials.Stat Med. 1996 Jun 15;15(11):1069-92. doi: 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.0.CO;2-Q. Stat Med. 1996. PMID: 8804140 Review.
-
The advantages and disadvantages of adaptive designs for clinical trials.Drug Discov Today. 2004 Apr 15;9(8):351-7. doi: 10.1016/S1359-6446(04)03023-5. Drug Discov Today. 2004. PMID: 15081962 Review.
Cited by
-
Resistance training and clinical status in patients with postdischarge symptoms after COVID-19: protocol for a randomized controlled crossover trial "The EXER-COVID Crossover Study".Trials. 2022 Aug 9;23(1):643. doi: 10.1186/s13063-022-06608-y. Trials. 2022. PMID: 35945634 Free PMC article.
-
Left ventricular systolic function after inhalation of beta-2 agonists in healthy athletes.Sci Rep. 2024 Oct 8;14(1):23437. doi: 10.1038/s41598-024-74095-z. Sci Rep. 2024. PMID: 39379505 Free PMC article. Clinical Trial.
-
The ELSA trial: single versus combinatory effects of non-prohibited beta-2 agonists on skeletal muscle metabolism, cardio-pulmonary function and endurance performance-study protocol for a randomized 4-way balanced cross-over trial.Trials. 2021 Dec 11;22(1):903. doi: 10.1186/s13063-021-05862-w. Trials. 2021. PMID: 34895300 Free PMC article.
MeSH terms
LinkOut - more resources
Medical